NCT04107805View on ClinicalTrials.gov

A Study in Healthy Men and Women to Test How Well Different Doses of BI 1323495 Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

March 5, 2021

Study Completion Date

March 26, 2021

Conditions
Healthy
Interventions
DRUG

BI 1323495

Tablet

DRUG

Placebo

Tablet

DRUG

Midazolam

Oral administration

Trial Locations (1)

30625

Fraunhofer ITEM, Hanover

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04107805 - A Study in Healthy Men and Women to Test How Well Different Doses of BI 1323495 Are Tolerated | Biotech Hunter | Biotech Hunter